Human Recombinant DYRK2, Active protein, GST Tag (V2LY-0526-LY3664)

Go to compare Compare Online Inquiry
Request for COA
Datasheet Target References Q & As Review & reward Protocols Associated Products

Basic Information

Expressed Host
E. coli
Protein Species
Human
Tag
GST Tag
Protein Construction
This product is Human Recombinant DYRK2, Active protein, GST Tag consist of Amino Acid: Full Length and predicts a molecular mass of 95 kDa.
Molecule Mass
95 kDa
Sequence
Amino Acid: Full Length
Species
Human

Formulations & Storage [For reference only, actual COA shall prevail!]

Purity
Batch dependent.
Endotoxin
Please contact us for more information.
Format
Liquid
Buffer
PBS
Preservative
None
Storage
Store product at -70°C. For optimal storage, aliquot target into smaller quantities after centrifugation and store at recommended temperature. For most favorable performance, avoid repeated handling and multiple freeze/thaw cycles.
More Infomation

Target

Full Name
Dual Specificity Tyrosine Phosphorylation Regulated Kinase 2
Research Area
Serine/threonine-protein kinase involved in the regulation of the mitotic cell cycle, cell proliferation, apoptosis, organization of the cytoskeleton and neurite outgrowth. Functions in part via its role in ubiquitin-dependent proteasomal protein degradation. Functions downstream of ATM and phosphorylates p53/TP53 at 'Ser-46', and thereby contributes to the induction of apoptosis in response to DNA damage. Phosphorylates NFATC1, and thereby inhibits its accumulation in the nucleus and its transcription factor activity. Phosphorylates EIF2B5 at 'Ser-544', enabling its subsequent phosphorylation and inhibition by GSK3B. Likewise, phosphorylation of NFATC1, CRMP2/DPYSL2 and CRMP4/DPYSL3 promotes their subsequent phosphorylation by GSK3B. May play a general role in the priming of GSK3 substrates. Inactivates GYS1 by phosphorylation at 'Ser-641', and potentially also a second phosphorylation site, thus regulating glycogen synthesis. Mediates EDVP E3 ligase complex formation and is required for the phosphorylation and subsequent degradation of KATNA1. Phosphorylates TERT at 'Ser-457', promoting TERT ubiquitination by the EDVP complex. Phosphorylates SIAH2, and thereby increases its ubiquitin ligase activity. Promotes the proteasomal degradation of MYC and JUN, and thereby regulates progress through the mitotic cell cycle and cell proliferation. Promotes proteasomal degradation of GLI2 and GLI3, and thereby plays a role in smoothened and sonic hedgehog signaling. Plays a role in cytoskeleton organization and neurite outgrowth via its phosphorylation of DCX and DPYSL2. Phosphorylates CRMP2/DPYSL2, CRMP4/DPYSL3, DCX, EIF2B5, EIF4EBP1, GLI2, GLI3, GYS1, JUN, MDM2, MYC, NFATC1, p53/TP53, TAU/MAPT and KATNA1. Can phosphorylate histone H1, histone H3 and histone H2B (in vitro). Can phosphorylate CARHSP1 (in vitro).
Biological Process
Cellular response to DNA damage stimulus Source: UniProtKB
Intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator Source: UniProtKB
Negative regulation of calcineurin-NFAT signaling cascade Source: UniProtKB
Peptidyl-serine phosphorylation Source: GO_Central
Peptidyl-threonine phosphorylation Source: GO_Central
Positive regulation of glycogen biosynthetic process Source: UniProtKB
Protein phosphorylation Source: UniProtKB
Regulation of signal transduction by p53 class mediator Source: Reactome
Smoothened signaling pathway Source: UniProtKB
Cellular Location
Nucleus; Cytoplasm. Translocates into the nucleus following DNA damage.
PTM
Autophosphorylates cotranslationally on the second tyrosine residue in the Tyr-X-Tyr motif in the activation loop, but once mature, does not have any protein tyrosine kinase activity. Phosphorylated at Thr-106 and Ser-442 by ATM in response to genotoxic stress.
Under normal conditions, polyubiquitinated in the nucleus by MDM2, leading to its proteasomal degradation. Phosphorylation on Thr-106 and Ser-442 by ATM in response to genotoxic stress disrupts MDM2 binding and prevents MDM2-mediated ubiquitination and subsequent proteasomal degradation. Polyubiquitinated by SIAH2, leading to its proteasomal degradation. Polyubiquitinated by SIAH2 oCcurs under normal conditions, and is enhanced in response to hypoxia.

Lara-Chica, M., Correa-Sáez, A., Jiménez-Izquierdo, R., Garrido-Rodríguez, M., Ponce, F. J., Moreno, R., ... & Calzado, M. A. (2022). A novel CDC25A/DYRK2 regulatory switch modulates cell cycle and survival. Cell Death & Differentiation, 29(1), 105-117.

Kawamura, A., Yoshida, S., Aoki, K., Shimoyama, Y., Yamada, K., & Yoshida, K. (2022). DYRK2 maintains genome stability via neddylation of cullins in response to DNA damage. Journal of Cell Science, 135(11), jcs259514.

Tandon, V., de la Vega, L., & Banerjee, S. (2021). Emerging roles of DYRK2 in cancer. Journal of Biological Chemistry, 296.

Moreno, R., Banerjee, S., Jackson, A. W., Quinn, J., Baillie, G., Dixon, J. E., ... & de la Vega, L. (2021). The stress-responsive kinase DYRK2 activates heat shock factor 1 promoting resistance to proteotoxic stress. Cell Death & Differentiation, 28(5), 1563-1578.

Correa-Sáez, A., Jiménez-Izquierdo, R., Garrido-Rodríguez, M., Morrugares, R., Muñoz, E., & Calzado, M. A. (2020). Updating dual-specificity tyrosine-phosphorylation-regulated kinase 2 (DYRK2): molecular basis, functions and role in diseases. Cellular and Molecular Life Sciences, 77(23), 4747-4763.

Yoshida, S., Aoki, K., Fujiwara, K., Nakakura, T., Kawamura, A., Yamada, K., ... & Yoshida, K. (2020). The novel ciliogenesis regulator DYRK2 governs Hedgehog signaling during mouse embryogenesis. Elife, 9, e57381.

Kumamoto, T., Yamada, K., Yoshida, S., Aoki, K., Hirooka, S., Eto, K., ... & Yoshida, K. (2020). Impairment of DYRK2 by DNMT1‑mediated transcription augments carcinogenesis in human colorectal cancer. International Journal of Oncology, 56(6), 1529-1539.

Yoshida, S., & Yoshida, K. (2019). Multiple functions of DYRK2 in cancer and tissue development. FEBS letters, 593(21), 2953-2965.

Park, C. S., Lewis, A. H., Chen, T. J., Bridges, C. S., Shen, Y., Suppipat, K., ... & Lacorazza, H. D. (2019). A KLF4-DYRK2–mediated pathway regulating self-renewal in CML stem cells. Blood, 134(22), 1960-1972.

Yokoyama-Mashima, S., Yogosawa, S., Kanegae, Y., Hirooka, S., Yoshida, S., Horiuchi, T., ... & Yoshida, K. (2019). Forced expression of DYRK2 exerts anti-tumor effects via apoptotic induction in liver cancer. Cancer letters, 451, 100-109.

Ask a question We look forward to hearing from you.
0 reviews or Q&As
Loading...
Have you used Human Recombinant DYRK2, Active protein, GST Tag?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon $30 eGift Card
Submit a review
Loading...
For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Contact us

  • Tel: (USA)
  • (UK)
  • Fax:
  • Email:

Submit A Review

online inquiry
Online Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.